BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 664118)

  • 1. The effect of O-(beta-hydroxyethyl)-rutoside (HR) on macromolecular leakage, thrombosis and haemostasis in experimental animals.
    Bergqvist D; Svensjö E; Arfors KE
    Ups J Med Sci; 1978; 83(2):123-7. PubMed ID: 664118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of the flavonoid O-(beta-hydroxyethyl)-rutoside on increased microvascular permeability induced by various agents in rat skin.
    Gerdin B; Svensjö E
    Int J Microcirc Clin Exp; 1983; 2(1):39-46. PubMed ID: 6088413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inhibition of PGE2-activity on FITC-dextran permeability in the hamster microvasculature.
    Svensjö E; Arfors KE; Arturson G
    Bibl Anat; 1975; 13():303-4. PubMed ID: 1231764
    [No Abstract]   [Full Text] [Related]  

  • 4. O-(beta-hydroxyethyl)-rutoside (Venoruton) fails to block histamine or bradykinin-induced edema formation in the canine forelimb perfused at constant arterial inflow.
    Dobbins DE; Soika CY; Dabney JM
    Microcirc Endothelium Lymphatics; 1984 Oct; 1(5):509-23. PubMed ID: 6546155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of o-(beta-hydroxyethyl)-rutoside in lymphangiography.
    Broks PD
    AJR Am J Roentgenol; 1977 Feb; 128(2):263-5. PubMed ID: 401613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
    ZFA (Stuttgart); 1981 Sep; 57(26):1758-60. PubMed ID: 7303836
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of O-(beta-hydroxyethyl)-rutoside or venoruton on lactate dehydrogenase of human cultured varicose veins.
    Matagne D; Hamoir G
    Biochem Pharmacol; 1975 Aug; 24(16):1491-4. PubMed ID: 1191306
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of capillary permeability and microcirculation in patients with chronic venous hypertension treated with venoruton by the vacuum suction chamber (VSC) device and laser-Doppler flowmetry.
    Belcaro G; D'Aulerio A; Rulo A; Candiani C
    Phlebologie; 1988; 41(4):847-56. PubMed ID: 3073400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reserpine inhibition of the hypotensive and permeability-promoting effect of O-hydroxyethyl derivatives of rutoside].
    Lecomte J; Damas J
    Arch Int Physiol Biochim; 1978 Dec; 86(5):1143-5. PubMed ID: 87166
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of O-(beta-hydroxyethyl)-rutoside (venoruton) on the adherence of leukocytes in patients with arteriosclerosis obliterans of the lower limbs].
    Lukjan H; Szpak A; Bodzenta A; Bielawiec M; Rosc D; Chyzy R
    Pol Arch Med Wewn; 1985 Jun; 73(6):345-50. PubMed ID: 3880372
    [No Abstract]   [Full Text] [Related]  

  • 11. [Venoruton and capillary permeability].
    Cesarone MR; Laurora G; Gabini M; Errichi BM; Candiani C; Belcaro G
    Minerva Cardioangiol; 1989 May; 37(5):265-8. PubMed ID: 2779806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of O-(beta-hydroxyethyl)-rutoside on wound healing in the rat.
    Wilhelmi G
    Pharmacology; 1979; 19(2):82-5. PubMed ID: 531085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of o-(beta-hydroxyethyl)-rutosides on the microrheology of human blood under defined flow conditions.
    Schmid-Schönbein H; Volger E; Weiss J; Brandhuber M
    Vasa; 1975; 4(3):263-70. PubMed ID: 1179829
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of tri- and tetra-O-(beta-hydroxyethyl)-rutoside on red blood cell aggregation of human blood.
    van Haeringen NJ
    Bibl Anat; 1975; 13():197-9. PubMed ID: 1231726
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study].
    Artaria LG
    Klin Monbl Augenheilkd; 1982 Jun; 180(6):568-70. PubMed ID: 6752553
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the effects of betabeta'-iminodipropionitrile and O-(beta-hydroxyethyl)-rutoside on ADP-activated aggregation of rat platelets in relation to the development of diabetic microangiopathy.
    Pollock J; Heath H
    Biochem Pharmacol; 1975 Feb; 24(3):397-400. PubMed ID: 1125047
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of Venoruton on the factor XIII activity in rat plasma.
    Grochal M; Sempińska-Edelberg E; Plewiński J
    Pol J Pharmacol Pharm; 1978; 30(5):659-63. PubMed ID: 751007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation and inhibition of biosynthesis of prostaglandins in human skin by some hydroxyethylated rutosides.
    Arturson G; Jonsson CE
    Prostaglandins; 1975 Dec; 10(6):941-8. PubMed ID: 1208886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hydroxyethyl rutosides upon the permeability of single capillaries in the frog mesentery.
    Blumberg S; Clough G; Michel C
    Br J Pharmacol; 1989 Apr; 96(4):913-9. PubMed ID: 2787181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticatatonic effect of venoruton.
    Aley KO; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):263-5. PubMed ID: 2898576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.